01/14/2025
4:00 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/14/2025
4:01 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Ratner Elena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 424B3 | |
11/18/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 424B3 | |
11/18/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 424B3 | |
11/17/2024
11:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form EFFECT | |
11/14/2024
5:45 AM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/14/2024
5:45 AM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/05/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/05/2024
11:42 AM | Cherington Charles (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/16/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form ARS | |
09/27/2024
3:47 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form PRE 14A | |
09/27/2024
3:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:36 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
4:00 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
3:32 PM | Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
Gurrola Sandra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
4:14 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
3:30 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:30 AM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 10-K/A | |
02/16/2024
4:30 PM | Cicala Peter (Reporting)
Eterna Therapeutics Inc. (Issuer)
Eterna Therapeutics Inc. (Issuer)
Brooklyn ImmunoTherapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/16/2024
6:30 AM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
6:05 AM | Eterna Therapeutics Inc. (Subject)
Eterna Therapeutics Inc. (Subject)
Brooklyn ImmunoTherapeutics (Subject)
HALPERN JOHN D (Filed by)
| Form SC 13G/A | |
01/22/2024
11:15 PM | Eterna Therapeutics Inc. (Filer)
Eterna Therapeutics Inc. (Filer)
Brooklyn ImmunoTherapeutics (Filer)
| Form EFFECT | |
